Filing metadata

Accession number
0000899243-23-013334
Form type
Form 3
Filer
Ambrx Biopharma Cayman, Inc.
CIK
CIK 1836056
Filed
May 19, 2023
Reporting period
May 18, 2023
Description
Initial ownership

Explore SEC Filings Hub